Abstract
The peripheral nervous system (PNS) is anatomically defined as all neural structures lying outside the pial membrane of the spinal cord and brain stem. The PNS encompasses the spinal roots, the nerve trunks, the dorsal root and autonomic ganglia, peripheral nerves, and the third to 12th cranial nerves. The olfactory and optic nerves are excluded since they are special extensions of the central nervous system (CNS). Consideration of the biology and anatomy of the PNS lies outside the scope of this chapter and interested readers are referred to other reviews.1,2
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dyck PJ, Thomas PK, Lambert EH, et al (eds): Peripheral Neuropathy, 2nd ed. Philadelphia, W.B. Saunders, 1984.
Asbury AK, Gilliatt RW: The clinical approach to neuropathy, in Asbury AK, Gilliatt RW (eds): Peripheral Nerve Disorders: A Practical Approach, London, Butterworths, 1984, pp 1–20.
Dyck Pi: Diseases of peripheral nerves, in Engel AG, Banker BQ (eds): Myology: Basic and Clinical. New York, McGraw-Hill, 1986, pp 2069–2108.
Spencer PS, Schaumberg HH (eds): Experimental and Clinical Neurotoxicology. Baltimore, Williams & Wilkins, 1980.
Middlebrook JL, Dorland RB: Bacterial toxins: cellular mechanism of action. Microbiol Rev 1984; 48: 199–221.
Morris RE, Saelinger CB: Entry of bacterial toxins into mammalian cells, in Simpson LL (ed): Botulinum Neurotoxin and Tetanus Toxin. San Diego, Calif, Academic Press, 1989, pp 121–152.
Waksman BH: Experimental study of diphtheritic polyneuritis in the rabbit and guinea pig. Part III. The blood-nerve barrier in the rabbit. J. Neuropathol Exp Neurol 1961; 20: 35–77.
Fisher CM, Adams RD: Diphtheritic polyneuritis: a pathological study. J. Neuropathol Exp Neurol 1956; 15: 243–268.
Bostock H, Sears TA, Sherratt RM: The spatial distribution of excitability and membrane current in normal and demyelinated mammalian nerve fibers. J. Physiol 1983; 341: 41–58.
Webster H, Spiro D, Waksman B, et al: Phase and electron microscopic studies of experimental demyelination. J Neuropathol Exp Neurol 1961; 20: 513.
Paley RG, Truelove SC: Diphtheria in the army in the United Kingdom. A study of its complications. J R Army Med Corps 1948; 90: 109–116.
Smith LDS: Botulism: The Organism, Its Toxin, The Disease. Springfield, Ill, Charles C Thomas, 1977.
Simpson LL: A comparison of pharmacological properties of Clostridium botulinum type C1 and C2 toxins. J. Pharmacol Exp Ther 1982; 223: 695–701.
Simpson LL: The pathophysiological actions of the binary toxin produced by Clostridium botulinum, in Eklund MW, Dowell VR Jr (eds): Avian Botulism: An International Perspective. Springfield, Ill, Charles C Thomas, 1987, pp 249–264.
Eklund MW, Poysky FT, Habig WH: Bacteriophages and plasmid in Clostridium botulinum and Clostridium tetani and their relationships to production of toxins, in Simpson LL (ed): Botulinum Neurotoxin and Tetanus Toxin. San Diego, Calif, Academic Press, 1989, pp 25–51.
DasGupta BR: Structure and structure function relation of botulinum neurotoxins, in Lewis GE (ed): Biomedical Aspects of Botulism. New York, Academic Press, 1981, pp 1–19.
Wright GP: The neurotoxins of Clostridium botulinum and Clostridium tetani. Pharmacol Rev 1955; 7: 413–465.
Baroff DA, Del Castillo J, Evoy WH, et al: Observations of the action of type A botulinum toxin on frog neuromuscular junctions. J Physiol 1974; 240: 227253.
MacDonald KL, Cohen ML, Blake PA: The changing adult botulism in the United States. Am J Epidemiol 1986; 124: 794–799.
Centers for Disease Control: MMWR 1986;35:490–491.
Kaplan JE, Davis LE, Narayan V, et al: Botulism, type A, and treatment with guanidine. Ann Neurol1979; 6: 69–71.
Bechelli LM, Martinez-Dominguez V: Further in- leprosy problem in the world. Bull WHO 1972; 46: 523–536.
Sabin TD, Swift TR: Leprosy, in Dyck PJ, Thomas PK, Lambert EH, et al (eds): Peripheral Neuropathy, 2nd ed., Philadelphia, WB Saunders, 1984, pp 1955–1987.
Van Voorhis WC, Kaplan G, Sarno EN, et al: The cutaneous infiltrates of leprosy. N Engl J Med 1982; 307: 1593–1597.
Noguera N, Kaplan G, Levy E, et al: Defective gam-ma-interferon production in leprosy. Reversal with antigen and interleukin 2. J Exp Med 1983; 158: 2165–2170.
Ottenhoff THM, Elferink DG, Klatser PR, et al: Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Nature 1986; 322: 462–464.
Modlin RL, Kato H, Mehira V, et al: Genetically restricted suppressor T cell clones derived from lepromatous leprosy lesions. Nature 1986; 322: 459–461.
Mshana RN, Humber DP, Harboe M, et al: Immune responses to bovine neural antigens in leprosy patients. Lepr Rev 1983; 54: 217–227.
Mshana RN, Humber DP, Harboe M, et al: Nerve herpes. damage following intraneural injection of Mycobac-terium leprae into rabbits pre-sensitized to mycobac herpes zoster. teria. Clin Exp Immunol 1983; 52: 441–448.
Kikuchi I, Ozawa T, Sanada K, et al: Immunogenetic analysis of leprosy in the Japanese; second report (abstract). Int J Lepr 1984; 52: 617.
Mshana RN, Harboe M, Stoner GL, et al.: Immune. responses to bovine neural antigens in leprosy patients. I. Absence of antibodies to an isolated myelin protein. Int J Lepr 1983; 51: 33–40.
Estis-Turf EP, Benjamins JA, Lefford MJ: Character ization of the antineural antibodies in the sera of leprosy patients. J Neuroimmunol 1986; 10: 313–330.
Weller TH, Witton HM: The etiologic agents of var- icella and herpes zoster: serologic studies with the viruses propagated in vitro. J Exp Med 1958; 108: 869–890.
Oldstone MBA: Molecular mimicry and autoimmune disease (minireview). Cell 1987; 50: 819–820.
Hope-Simpson RE: The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965; 59: 9–20.
Ruppenthal M: Changes of the central nervous system herpes zoster. Acta Neuropath 1980; 52: 59–68.
Gilden DH, Vafai A, Shtram Y, et al: Varicella-zoster virus DNA in human sensory ganglia. Nature 1983; 306: 478–480.
Hyman RW, Ecker JR, Tenser RB: Varicella-zoster virus RNA in human trigeminal ganglia. Lancet1983; 2: 814–816.
Ropper AH: Campylobacter diarrhea and Guillain-formation on the Barré syndrome. Arch Neurol 1988; 45: 655–656.
Arnason BGW: Acute inflammatory demyelinating polyradiculoneuropathies, in Dyck PJ, Thomas PK, Lambert EH, et al (eds): Peripheral Neuropathy, 2nd ed, Philadelphia, WB Saunders, 1984, pp 2050–2100.
McKhann GM, Griin JW, Cornblath DR, et al: Plas-mapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis.Ann Neurol 1988; 23: 347–353
McKhann GM, Griffin JW, Cornblath DR, et al: Role of therapeutic plasmapheresis in the acute Guillain-Barré syndrome. J Neuroimmunol 1988; 20: 297–300.
Koski CL, Chou DK, Jungalwala FB: Anti-peripheral nerve myelin antibodies in Guillain-Barré syndrome bind a neutral glycolipid of peripheral nerve myelin and cross-react with Forssman antigen. J. Clin Invest 1989; 41: 280–287
Kennedy PGE: Neurological complications of var-icella-zoster virus, in Kennedy PGE, Johnson RT (eds): Infections of the Nervous System. London, But-terworths, 1987, pp 177–208
Denny-Brown D, Adams RD, Fitzgerald P: Patholog-ic features of herpes zoster: a note on “Geniculate” herpes Arch Neurol Psychiatry 1944; 51: 216–231.
Ghatak NR, Zimmerman HM: Spinal ganglion in A light and electron microscopic study.Arch Pathol 1973; 95: 411–415.
Esiri MM, Tomlinson AH: Herpes zoster demonstra-tion of virus in trigeminal nerve and ganglion by immunofluoresce, and electron microscopy. J Neurol Sci 1972; 15: 35–48
Swift TR, Rivner MH. Infectious diseases of nerve,in Vinken PJ, Bruyn GW, Klawans HL (eds): Hand- book of Clinical Neurology, Vol 51, Revised Series 7:Neuropathies (Mathews WB, co-ed). Amsterdam, Elsevier Science Publishing, 1987; pp 179–194.
Thomas JE, Howard FM Jr: Segemental zoster pare-sis-a disease profile. Neurology 1972; 22: 459–466.
Hunt JR: On herpetic inflammations of the geniculate ganglion. A new syndrome and its complications. J. Nery Ment Dis 1907; 34: 73–96.
Seljma KW, Raine CS: Tumor necrosis factor medi-ates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988; 23: 339–346.
WHO Study Group: Chemotherapy of leprosy for control programmes. WHO Technical Report Series No. 675, 1982.
WHO Geneva: Treatment and patient care, in A Guide to Leprosy Control, Ch 6. WHO, Geneva, 1988, pp. 30–46.
Jacobson RR, Trautman JR: The treatment of leprosy with the sulfones. I. Faget’s original 22 patients; a thirty year follow-up on sulfone therapy for leprosy. Int J Lepr 1971: 39: 726.
Rosenblum ML, Levy RM, Bredesen DE (eds): AIDS and the Nervous System. New York, Raven, 1988.
Cornblath DR, McArthur JC, Kennedy GE, at al: Inflammatory demyelinating peripheral neuropathies with human T-lymphotropic virus type III amyotrophic lateral sclerosis, infection. Ann Neurol 1987; 21: 32–40.
Miller RG, Parry G, Lang W, et al: AIDS-related inflammatory polyradiculoneuropathy: prediction of response to plasma exchange with electrophysiologic testing. Muscle Nerve 1985; 8: 626.
Bailey RO, Singh JK, Bishop MB: AIDS neuropathy: the role of axoplasmic transport. Neurology 1987;. 37(suppl 1 ): 356.
So YT, Holtzman DM, Abrams DI, et al: Peripheral neuropathy associated with acquired immunodefi ciency syndrome: prevalence and clinical features from a population-based survey. Arch Neurol n1988; 45: 945–948.
Yarchoan R, Brouwers P, Spitzer AR, et al: Re- sponse of human-immunodeficiency-virus-associated neurological disease to 3’ -azido-3’ deothymidine.Lancet 1987; 1: 132–135.
Said G, Lacroix-Ciaudo C, Fujimara H, et al: The peripheral neuropathy of necrotizing arteritis: a clini-copathological study. Ann Neurol 1988; 23: 46–465.
Eidelberg D, Sotrel A, Vogel H, et al: Progressive polyradiculopathy in acquired immune deficiency syndrome. Neurology 1986; 36: 912–916
Behar R, Wiley C, McCutchan JA: Cytomegalovirus polyradiculoneuropathy in acquired immune de ficiency syndrome. Neurology 1987; 37: 557–561.
Grafe MR, Wiley CA: Spinal cord and peripheral nerve pathology in AIDS: the roles of cytomegalovirus and human immunodeficiency virus. Ann Neurol 1989; 25: 561–566.
Salazar-Grueso EF, Dawson G, Wollman R, et al: HTLV-I infection associated with a familial spastic paraparesis (FSP) syndrome (abstract). Ann Neurol26(1): 152, 1989.
Vernant J-C, Buisson G, Bellance R, et al: Pseudo- associated peripheral neuropathy and chronic polyradiculoneuritis in HTLV-I-asso-ciated paraplegias, in Roman GC, Vernant J-C,Osame M (eds): HTLV-I and the Nervous System.New York, Alan R Liss, 1989; pp 361–365.
Said G, Joskowicz M, Barreira Antunes A, et al: Neuropathy associated with experimental Chagas dis-ease. Ann Neurol 1985; 18: 676–683
Pagano MA, Basso S, Aristimuno GG, et al: Elec-tromyographical findings in human chronic Chagas disease. Arq Neuro-Psiquiatr 1978; 42: 316–318.
Brener Z: Recent advances in the chemotherapy of Chagas disease. Mem Inst Oswaldo Cruz 1984; 79 (suppl): 149–155.
Pappenheimer Jr AM: Diphtheria toxin. Ann Rev Biochem 1977; 46: 69–94.
Margileth A, Strano A, Chandra R, et al: Dis-seminated nosematosis in an immunologically com-promised infant. Arch Pathol 1973; 95: 145–150.
Jolleys JV: Treatment of shingles and post-herpetic neuralgia (editorials). Br Med J 1989; 298: 1537–1538
McKendrick MW, McGill JI, Wood MW. Lack of. effect of acyclovir on postherpetic neuralgia. Br Med 1989; 289: 431.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Salazar-Grueso, E.F., Arnason, B.G. (1990). Peripheral Nerve Disease Caused by Infection, Toxins, and Postinfectious Syndromes. In: Schlossberg, D. (eds) Infections of the Nervous System. Clinical Topics in Infectious Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-9698-7_15
Download citation
DOI: https://doi.org/10.1007/978-1-4613-9698-7_15
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4613-9700-7
Online ISBN: 978-1-4613-9698-7
eBook Packages: Springer Book Archive